Issuance of Shares and Increase in Capital Through Exercise of Stock Acquisition Rights
First written in FY2018-Q2. 31 of 32 entries say "Advanced", first in FY2018-Q3. Latest entry: FY2026.
102 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「1 July 2025 to 30 June 2026 (Note) 1. 43,500 16,261,800 6,684 1,220,842 6,684 1,205,842」
In FY2026, 43,500 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥6.684 million each. - 2026-08-06AdvancedEarnings
「Issuance of new shares 6,684 6,684 6,684 13,368 13,368」
New shares were issued during the fiscal year through the exercise of stock acquisition rights and other activities, increasing both stated capital and the capital surplus by ¥6.684 million. - FY2026-H1AdvancedAnnual report
「1 July 2025 to 31 December 2025 (Note) 25,400 16,243,700 3,743 1,217,900 3,743 1,202,900 (Note) Increase due to the exercise of stock acquisition rights.」
During the interim accounting period, 25,400 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥3.743 million each. - FY2025AdvancedAnnual report
「1 July 2024 to 30 June 2025 (Note) 1. 12,500 16,218,300 2,031 1,214,157 2,031 1,199,157」
In FY2025, 12,500 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥2.031 million each. - FY2025-H1AdvancedAnnual report
「1 July 2024 to 31 December 2024 (Note) 6,400 16,212,200 1,040 1,213,166 1,040 1,198,166 (Note) Increase due to the exercise of stock acquisition rights.」
During the interim accounting period, 6,400 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥1.040 million each. - FY2024AdvancedAnnual report
「1 July 2023 to 30 June 2024 (Note) 1. 90,200 16,205,800 13,538 1,212,126 13,538 1,197,126」
During the fiscal year, 90,200 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥13.538 million each. - FY2024-Q3AdvancedAnnual report
「1 January 2024 to 31 March 2024 (Note) 11,800 16,172,500 1,731 1,207,056 1,731 1,192,056 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter accounting period, 11,800 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥1.731 million each. - FY2024-Q2AdvancedAnnual report
「1 October 2023 to 31 December 2023 (Note) 2,800 16,160,700 455 1,205,324 455 1,190,324 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter accounting period, 2,800 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥455,000 each. - FY2024-Q1AdvancedAnnual report
「1 July 2023 to 30 September 2023 (Note) 42,300 16,157,900 6,281 1,204,869 6,281 1,189,869 (Note) Increase due to the exercise of stock acquisition rights.」
During the cumulative first quarter period, 42,300 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥6.281 million each. - FY2023AdvancedAnnual report
「1 July 2022 to 30 June 2023 (Note) 1. 90,800 16,115,600 13,344 1,198,588 13,344 1,183,588」
During the fiscal year, 90,800 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥13.344 million each. - FY2023-Q3AdvancedAnnual report
「1 January 2023 to 31 March 2023 (Note) 21,800 16,081,100 2,984 1,193,248 2,984 1,178,248 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter accounting period, 21,800 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥2.984 million each. - FY2023-Q2AdvancedAnnual report
「1 October 2022 to 31 December 2022 (Note) 6,000 16,059,300 875 1,190,263 875 1,175,263 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter accounting period, 6,000 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥875,000 each. - FY2023-Q1AdvancedAnnual report
「1 July 2022 to 30 September 2022 (Note) 28,500 16,053,300 4,144 1,189,388 4,144 1,174,388 (Note) Increase due to the exercise of stock acquisition rights.」
During the cumulative first quarter period, 28,500 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥4.144 million each. - FY2022AdvancedAnnual report
「Proceeds from the issuance of shares upon the exercise of stock acquisition rights: ¥39.362 million」
During the fiscal year, 139,200 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥19.681 million each. - FY2022-Q3AdvancedAnnual report
「1 January 2022 to 31 March 2022 (Note) 46,300 16,009,900 6,863 1,183,147 6,863 1,168,147 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter accounting period, 46,300 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥6.863 million each. - FY2022-Q2AdvancedAnnual report
「1 October 2021 to 31 December 2021 (Note) 39,900 15,963,600 5,246 1,176,284 5,246 1,161,284」
During the second quarter accounting period, 39,900 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥5.246 million each. - FY2022-Q1AdvancedAnnual report
「1 July 2021 to 30 September 2021 (Note 2) 38,100 15,923,700 5,475 1,171,037 5,475 1,156,037 (Note) 2. Increase due to the exercise of stock acquisition rights.」
During the cumulative first quarter period, 38,100 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥5.475 million each. - FY2021AdvancedAnnual report
「Proceeds from the issuance of shares upon the exercise of stock acquisition rights: ¥65.130 million」
During the fiscal year, 116,700 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥32.565 million each. - FY2021-Q3AdvancedAnnual report
「1 January 2021 to 31 March 2021 (Note) 30,800 7,913,500 8,772 1,157,633 8,772 1,142,633 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter accounting period, 30,800 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥8.772 million each. - FY2021-Q2AdvancedAnnual report
「1 October 2020 to 31 December 2020 (Note) 15,200 7,882,700 4,602 1,148,861 4,602 1,133,861 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter accounting period, 15,200 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥4.602 million each. - FY2021-Q1AdvancedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
During the cumulative first quarter period, 41,400 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥11.261 million each. - FY2020AdvancedAnnual report
「Proceeds from the issuance of shares upon the exercise of stock acquisition rights: ¥38.377 million」
During the fiscal year, 66,600 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥19.188 million each. - FY2020-Q3AdvancedAnnual report
「1 January 2020 to 31 March 2020 41,600 7,826,100 11,951 1,132,997 11,951 1,117,997 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter accounting period, 41,600 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥11.951 million each. For the cumulative third quarter period, the increase was 66,600 shares, while share capital and the capital surplus increased by ¥19.188 million each. - FY2020-Q2AdvancedAnnual report
「1 October 2019 to 31 December 2019 (Note) 2 18,000 7,784,500 4,962 1,121,046 4,962 1,106,046」
During the second quarter accounting period, 18,000 shares were issued upon the exercise of stock acquisition rights, increasing share capital and the capital surplus by ¥4.962 million each. The cumulative increase was 25,000 shares. - FY2020-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the cumulative first quarter, 7,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥2.275 million each. - FY2019AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the current fiscal year, 59,150 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥44.372 million each. - FY2019-Q3AdvancedAnnual report
「1 January 2019 to 31 March 2019」
During the current third-quarter accounting period, 20,100 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥4.021 million each. - FY2019-Q2AdvancedAnnual report
「This was due to ¥20.22 million in proceeds from the issuance of shares through the exercise of stock acquisition rights.」
On 1 November 2018, 26,900 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥6.472 million each. - FY2019-Q1AdvancedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
From 1 July 2018 to 30 September 2018, 6,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥3.637 million each. - FY2018AdvancedAnnual report
「Net cash provided by financing activities was ¥9.18 million, compared with ¥546.57 million in the same period of the previous year. This was due to ¥9.18 million in proceeds from the issuance of shares through the exercise of stock acquisition rights.」
In FY2018, 36,600 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥4.59 million each. - FY2018-Q3AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
From 1 January 2018 to 31 March 2018, 2,850 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥1.496 million each. - FY2018-Q2First statedAnnual report
「Net cash provided by financing activities was ¥2.1 million, compared with none in the same period of the previous year. This was due to ¥2.1 million in proceeds from the issuance of shares through the exercise of stock acquisition rights.」
During the cumulative second quarter, 28,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥1.05 million each.